MarketPeel
Insider Trading Intelligence
Pricing
…
RN

Rodger Novak

CRSP
PRESIDENT · CRISPR THERAPEUTICS AG · CIK 0001682017
FILING MIX · LIFETIME23%/77%
BUYS
9
SELLS
30
TOTAL VALUE
$44.35M
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
573,007
AVG SELL PX
$97.83
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
21 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Rodger Novak, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d21+42.86%+4.21%+0.60%+3.61%+1.94%—
14d21+47.62%+3.16%+2.20%+0.96%-1.24%—
30d21+57.14%-0.37%+2.33%-2.71%-4.16%—
60d21+57.14%+8.63%+4.76%+3.88%+5.31%—
90d21+42.86%+14.07%+6.56%+7.51%+0.51%—
180d21+42.86%+18.78%+14.96%+3.82%+8.48%—
1y21+42.86%+5.41%+17.91%-12.50%-25.77%—
2y21+100.00%-38.66%+16.79%-55.44%-60.08%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRSP · 573,007 shares · as of Jun 30, 2021
0199,502399,004598,505798,0072021SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
FLOW · 9 buys / 30 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CRSP
CRISPR THERAPEUTICS AG
SALE
President
25,000$165.00$4.13M573,007Jun 30, 2021Jul 1, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
25,000$156.55$3.91M598,007Jun 28, 2021Jun 30, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
881$126.62$111.6K645,955Jun 21, 2021Jun 23, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
7,299$129.46$944.9K623,057Jun 21, 2021Jun 23, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
1,171$125.58$147.1K646,836Jun 21, 2021Jun 23, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
12,630$128.76$1.63M630,356Jun 21, 2021Jun 23, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
2,969$127.71$379.2K642,986Jun 21, 2021Jun 23, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
50$130.27$6.5K623,007Jun 21, 2021Jun 23, 2021 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
50,000——140,315Nov 30, 2020Dec 2, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
50,000$125.00$6.25M648,007Nov 30, 2020Dec 2, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
50,000$14.00$700.0K698,007Nov 30, 2020Dec 2, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
50,000$14.43$721.5K698,007Nov 30, 2020Dec 2, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
50,000——61,893Nov 30, 2020Dec 2, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
2,762$14.43$39.9K650,769Oct 9, 2020Oct 13, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
2,762$100.00$276.2K648,007Oct 9, 2020Oct 13, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
2,762——190,315Oct 9, 2020Oct 13, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
22,238——193,077Oct 8, 2020Oct 13, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
22,238$14.43$320.9K670,245Oct 8, 2020Oct 13, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
22,238$100.00$2.22M648,007Oct 8, 2020Oct 13, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
3,840$93.19$357.8K648,007Sep 1, 2020Sep 3, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
21,067——215,315Sep 1, 2020Sep 3, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
3,933——111,893Sep 1, 2020Sep 3, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
21,067$14.43$304.0K673,007Sep 1, 2020Sep 3, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
1,406$91.54$128.7K671,601Sep 1, 2020Sep 3, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
19,754$92.59$1.83M651,847Sep 1, 2020Sep 3, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
3,933$14.00$55.1K651,940Sep 1, 2020Sep 3, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
25,000——115,826Aug 19, 2020Aug 21, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
25,000$14.00$350.0K673,007Aug 19, 2020Aug 21, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
25,000$100.00$2.50M648,007Aug 19, 2020Aug 21, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
5,586——0Jul 7, 2020Jul 9, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
19,414——140,826Jul 7, 2020Jul 9, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
25,000$90.00$2.25M648,007Jul 7, 2020Jul 9, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
5,586$1.81$10.1K653,593Jul 7, 2020Jul 9, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
PURCHASE
President
19,414$14.00$271.8K673,007Jul 7, 2020Jul 9, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
50,000$80.00$4.00M648,007Jul 1, 2020Jul 6, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
50,000$75.00$3.75M698,007Jun 23, 2020Jun 25, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
36,616$70.27$2.57M748,007May 26, 2020May 27, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
13,384$70.01$937.0K784,623May 22, 2020May 27, 2020 ↗View →
CRSP
CRISPR THERAPEUTICS AG
SALE
President
50,000$65.00$3.25M798,007May 19, 2020May 21, 2020 ↗View →
Other insiders · CRSP
Loading peer insiders…
About this filer
CIK 0001682017
ROLE
President
PRIMARY
CRSP
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001682017DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback